Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

This study has been completed.
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Schering-Plough
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00879034
First received: April 8, 2009
Last updated: April 20, 2010
Last verified: April 2010